1. Introduction {#sec1}
===============

It is well understood that the aging brain has a decreased capacity to recover following injury. This may be due in part to localized changes to the neuronal and glial intrinsic and extrinsic environment as the animal ages. The magnocellular neurosecretory system, which contains oxytocin- and vasopressin-producing magnocellular neurons with their somata located in the supraoptic nucleus (SON) and their axons that project via the infundibulum to terminate in the neural lobe (NL; posterior pituitary), has been extensively studied following axotomy. Numerous reports have shown that injury to the axons of the magnocellular neuron results in post-injury regenerative growth ([@bib38]; [@bib39]; [@bib1]; [@bib32], [@bib33]; [@bib43]; [@bib41]; [@bib29]; [@bib55]; [@bib54]). To this point, previous reports demonstrated that unilateral lesion of the hypothalamo-neurohypophysial tract, which severs the axons in the ipsilateral SON while sparing the contralateral SON axons, results in the loss of 42% of the axons in the NL at one-week post-lesion, followed by a collateral sprouting response to return the axon numbers to control levels by four-week post-lesion in 35-day-old (35d) rats ([@bib55]; [@bib54]). Conversely, unilateral lesion in 125-day-old (125d) rat does not induce a collateral axonal sprouting response ([@bib5]), indicating that a loss of axonal plasticity in the rat SON occurs between 35d and 125d. What promotes the post-injury collateral sprouting response in the 35d rat and what changes occur in the SON between 35d and 125d rats that precludes the sprouting response following injury in the 125d rat has yet to be determined.

Our central hypothesis is that the post-injury sprouting response following unilateral lesion is promoted by ciliary neurotrophic factor (CNTF), which is only found in astrocytes in the SON ([@bib52]). In support of this hypothesis, our lab, and others, have shown that CNTF promotes axonal sprouting ([@bib4]) and neuron survival ([@bib51]; [@bib44], [@bib45]; [@bib3]; [@bib4]) following axotomy in hypothalamic organotypic cultures containing the SON. Moreover, CNTF protein levels are elevated during the sprouting response in the 35d rat SON ([@bib52]; [@bib2]), and the CNTF specific receptor, CNTF receptor alpha (CNTFRα), is decreased in the absence of injury in the 125d rat SON ([@bib5]). Collectively, these data suggest that CNTF may be involved in the axonal sprouting from uninjured neurons following unilateral lesion. Although, if CNTF does promote the collateral sprouting response in the SON it has to act indirectly via astrocytes, which are the only cell in the SON that contains all three (CNTFRα, LIFRß, and gp130) of the CNTF receptor components ([@bib2]). Thus, we believe understanding the cellular interactions between astrocytes and neurons in the SON will be paramount to understanding the possible post-injury role that CNTF plays in the SON.

Previous reports have demonstrated that CNTF expression is down-regulated by cell adhesion molecule interactions (CAMs), specifically, interactions between neuronal Thy-1 and astrocytic α~v~ß~5~ integrin ([@bib28]; [@bib30]). Within the nervous system, the functions of CAMs are diverse but are primarily focused with general cellular adhesion, myelin formation, synapse formation, neurite bundling, and gap junction formation ([@bib47]). Numerous reports demonstrate that CAMs are necessary for neurite outgrowth and axon guidance during development ([@bib19]; [@bib20]; [@bib21]), in addition to promoting neuron survival and axonal sprouting functions following axotomy ([@bib17], [@bib18]; [@bib50]). More specifically, integrin proteins have been linked to the inhibition of axon outgrowth, specifically due to their interaction with Thy-1 ([@bib23]). Thy-1 (thymocyte antigen 1, CD90) is a GPI-anchored glycoprotein found on the extracellular surface of neurons and has been shown to inhibit axon outgrowth by interacting with integrins on astrocytes ([@bib49]; [@bib34]; [@bib7], [@bib6], [@bib8]). Integrins function as heterodimers of transmembrane polypeptides, alpha (α) and beta (ß) chains, and α~V~ß~3~ ([@bib34]; [@bib22]; [@bib8]) and α~V~ß~5~ ([@bib58]; [@bib30]) have been shown to be the astrocytic receptors for neuronal Thy-1. Thus, these reports suggest that neuronal Thy-1 and astrocytic integrins may be involved in preventing or repressing axonal outgrowth. While Thy-1 is present in axons of magnocellular neurons at the site of the axon terminals in the NL ([@bib37]), to date, little is known about Thy-1 or integrin protein localization in the SON. Therefore, we sought to characterize the cellular localization of Thy-1, α~V~ integrin, ß~3~ integrin, and ß~5~ integrin in the SON and determine if the protein levels of these CAMs change with age in the SON and NL. We believe these experiments will help clarify the age-dependent changes following axotomy to the neurons in the SON as well as the role that CNTF may play in promoting the post-injury collateral sprouting response in the NL.

2. Materials and methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

We purchased male Sprague-Dawley rats from Envigo (Minneapolis, MN) and they were housed in the vivarium in the Integrated Science Center on the campus of Concordia College under a 12L:12D light cycle with ad libitum access to lab chow and tap water. Animal care protocols utilized in these studies complied with all appropriate federal and state laws, as well as with NIH guide for the care and use of laboratory animals, with approval from the Concordia College Institutional Animal Care and Use Committee (\#AUP_BIO_2018.03). Rats used in this study were received between 30-35 or 120--125 days of age and were allowed to adapt to the colony room for several days before sacrifice between either 35--40 days of age (75--100 g) or 125--130 days of age (450--550 g).

2.2. Gel electrophoresis and western blot {#sec2.2}
-----------------------------------------

Experimental procedures were conducted as previously stated ([@bib2], [@bib3]; [@bib5]). Once the rats were approximately 35- or 125-days old, they were anesthetized with sodium pentobarbital (35 mg/kg, i.p.; Sigma; St. Louis, MO) ([@bib13]), decapitated, and their brains were removed intact. SON and NL samples were carefully dissected under a dissecting microscope and pooled from three rats in a solution of radioimmuno-precipitation assay buffer containing 1% protease inhibitor (Sigma) and 1% phosphatase inhibitor (Sigma). The tissue samples were then sonicated and centrifuged at 4 °C. We used the bicinchoninic acid colorimetric detection assay (Pierce BCA Protein Assay; Pierce) to determine total protein content in the SON and NL samples, and supernatant from each sample was stored at -80 °C until needed.

Using a 12% SDS-PAGE gel (Precise Protein Gels; Pierce), each lane was loaded with 25 μg of protein from the SON or NL, and proteins were separated at 90 V for approximately 1.25 h and then electrophoretically transferred to a PVDF membrane (0.2 μm; Bio-Rad, Hercules, CA) at 70 V for 2 h. After blocking non-specific binding sites with the appropriate blocking buffer listed according to the antibody data sheet (5% bovine serum albumin or 5% milk in phosphate-buffered saline (PBS) plus 0.1% Tween-20), we incubated the membrane overnight at 4 °C in mouse anti-Thy-1 (1:1000; \#MAB1406, Millipore; Burlington, MA). The membranes were then washed repeatedly for 1 h in PBS-Tween and incubated for 2 h in the species-appropriate HRP-conjugated secondary antibody (1:50,000; Santa Cruz Biotechnology; Santa Cruz, CA). The bands were subsequently visualized following 2 h of PBS washes using the West Femto chemiluminescent detection kit (Pierce) with chemiluminescence film (Amersham Hyperfilm ECL; GE Healthcare; VWR; West Grove, PA) developed in a darkroom using Kodak film development chemicals (Sigma). Afterward, bound antibodies were removed with stripping buffer (pH 2.2; 15g glycine; Sigma, 1g SDS; Bio-Rad, 10 ml Tween-20; Bio-Rad in 1 L ultrapure water). The previously listed steps were repeated to sequentially reprobe the membrane for the following antibodies; rabbit anti-α~V~ integrin (1:1000; \#4711, Cell Signaling Technology, Inc., Danvers, MA), rabbit anti-ß~3~ integrin (1:2000; \#13166, Cell Signaling), rabbit anti-ß~5~ integrin (1:1000; \#3629, Cell Signaling), and mouse anti-ß-actin (1:50,000; \#A2228, Sigma).

Densitometric analysis of immunoblot signals was performed using Image J (NIH). Digitized western blot films were opened in Image J, bands of interest were outlined with a rectangle, and the areal density of the band was calculated by histogram analysis. The density of all bands was normalized to ß-actin band density to obtain ratios. The analysis was repeated on three separate samples per group resulting in mean ratio values for each group that was used for statistical analysis as described below.

2.3. Dual-label fluorescent immunocytochemistry {#sec2.3}
-----------------------------------------------

Experimental procedures were conducted as previously stated ([@bib2], [@bib3]). Rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and transcardially perfused with approximately 50 mL of 0.9% saline followed by approximately 500 mL of periodate-lysine-paraformaldehyde fixative (PLP; 3.2% paraformaldehyde, 2.2% lysine, 0.33% sodium-(meta) periodate; Sigma) that was prepared immediately before use ([@bib36]). Brains were removed, trimmed to contain the SON, and post-fixed in PLP overnight before cryoprotection in 25% sucrose in PBS. Cryosections (16 μm) were obtained using a cryostat (Microm HM550; Fisher Scientific) and mounted on gelatin-coated slides and stored at -20 °C until use.

Cryosections were washed with PBS containing 0.3% Triton X-100 (PBS-T; Sigma) in 5 × 10 min intervals before and after all incubations. Non-specific staining was alleviated by treatment with blocking buffer (4% of the appropriate normal serum (Vector, Burlingame, CA) in PBS-T) for 1 h at room temperature before an overnight incubation at 4 °C in mouse anti-Thy-1 (1:50; \#MAB1406, Millipore), rabbit anti-α~V~ integrin (1:25; \#60896, Cell Signaling), rabbit anti-ß~3~ integrin (1:25; \#13166, Cell Signaling), or rabbit anti-ß~5~ integrin (1:50; \#3629, Cell Signaling). Sections were then incubated in the species-appropriate biotinylated IgG secondary antibody (1:500; Vector) for 1 h followed by either the astrocyte-specific antibody, mouse anti-GFAP (1:1000; \#G-3893, Sigma), or a SON neuron-specific antibody, guinea pig anti-oxytocin (1:1000; \#T-5021, Peninsula Laboratories, San Carlos, CA) or guinea pig anti-vasopressin (1:1000; \#T-5048, Peninsula Laboratories). The antibodies were fluorescently labeled using a cocktail of Alexa streptavidin 488 or 594 (1:1000; Molecular Probes, Eugene, OR) with species-specific secondary IgG conjugated to either Alexa Fluor 488 or Alexa Fluor 594 (1:200; Molecular Probes) and cryosections were coverslipped using Vectashield mounting medium (Vector).

Images of the SON were acquired using 20x, 60x oil-immersion, or 100x oil-immersion objectives on an Olympus BX-51 fluorescent microscope with mounted DP-71 color camera and dedicated software. Colocalization of Thy-1 and the integrin subunits with neuronal or astrocytic markers were quantified with ImageJ software using the colocalization colormap plugin to calculate the Correlation Index (Icorr) ([@bib27]), which indicates the fraction of positively correlated pixels in the image. For each antibody of interest, we performed quantitative analysis from a minimum of three rats and used at least three cryosections sampled throughout the entire rostral-caudal SON. To ensure that the same cells were not analyzed twice, a minimum of five sections (80 μm) were skipped before the next cryosection was immunocytochemically processed. The DP-71 camera software was used to adjust the brightness and contrast on an entire image while avoiding the misrepresentation of any information present in the original image while treating every pixel in each image the same.

As a control for the dual-label fluorescence immunocytochemistry, incubations with the antibodies for the proteins of interest (Thy-1 and integrin subunits) on separate cryosections were followed by incubation with the species-specific fluorescent-conjugated secondary antibodies for the cell-specific markers (anti-GFAP, -OT, and -VP). Similarly, tissue that was incubated with the anti-GFAP, -OT, or -VP antibodies was exposed to the fluorescent-conjugated secondary antibodies for Thy-1 or the integrin subunits. These controls demonstrated an absence of fluorescent immunoreactivity in the rat SON, indicating that the fluorescent-conjugated secondary antibodies were specific for their appropriate primary antibody, and there was no observable cross-reactivity between the secondary antibodies (data not shown).

2.4. Statistical analysis {#sec2.4}
-------------------------

Quantitative data was tested for distribution normality using the Kolmogorov-Smirnov test for normality (GraphPad Prism, version 6.0; San Diego, California). Individual group comparisons were performed using Student\'s *t* test with *p \< 0.05* considered as statistically significant. Results presented herein are expressed as the group means ± SD.

3. Results {#sec3}
==========

3.1. Thy-1 protein increases with age in the SON {#sec3.1}
------------------------------------------------

Western blot analysis demonstrated a statistically significant increase of 801% in Thy-1 protein levels in the 125d SON compared to the 35d SON (*p=0.0245*; [Figure 1](#fig1){ref-type="fig"}a). However, we found no significant change in α~V~ integrin protein levels (*p=0.7441*; [Figure 1](#fig1){ref-type="fig"}b), ß~3~ integrin protein levels (*p=0.9452*; [Figure 1](#fig1){ref-type="fig"}c), or ß~5~ integrin protein levels (*p=0.6292*; [Figure 1](#fig1){ref-type="fig"}d) in the 125d SON compared to the 35d SON. Protein analysis in the NL demonstrated no significant change in Thy-1 protein levels (*p=0.6837*; [Figure 2](#fig2){ref-type="fig"}a), α~V~ integrin protein levels (*p=0.8905*; [Figure 2](#fig2){ref-type="fig"}b), ß~3~ integrin protein levels (*p=0.7624*; [Figure 2](#fig2){ref-type="fig"}c), or ß~5~ integrin protein levels (*p=0.2731*; [Figure 2](#fig2){ref-type="fig"}d) in the 125d NL compared to the 35d NL. Together, these data indicate that as the rat ages, there is more Thy-1 protein in the SON but no change in the integrin subunits in the SON or NL between 35d and 125d.Figure 1More Thy-1 protein present in the 125d SON. Western blot analysis revealed a significant increase of 801% in Thy-1 protein levels in the 125d SON compared to 35d SON (a; *p=0.0245*). Additionally, our results revealed no change in protein levels of α~V~ integrin (b; *p=0.74*), ß~3~ integrin (c; *p=0.95*), or ß~5~ integrin (d; *p=0.63*) in the 125d SON compared to 35d SON. Representative protein bands with their molecular weights are presented in (e). Each shape on the graph indicates an individual data point with the lines representing the mean and SD. Each data point represents isolated SON pooled from three rats and analysis was repeated on three separate samples per group.Figure 1Figure 2No change in Thy-1 or integrin subunit protein levels between 35d and 125d in the NL. Western blot analysis revealed no change in Thy-1 protein levels (a; *p=0.68*), α~V~ integrin (b; *p=0.89*), ß~3~ integrin (c; *p=0.76*), or ß~5~ integrin (d; *p=0.27*) in the 125d NL compared to 35d NL. Representative protein bands with their molecular weights are presented in (e). Each shape on the graph indicates an individual data point with the lines representing the mean and SD. Each data point represents isolated SON pooled from three rats and analysis was repeated on three separate samples per group.Figure 2

3.2. Thy-1-, α~V~ integrin-, ß~3~ integrin-, and ß~5~ integrin-immunoreactivity is localized to magnocellular neurons and astrocytes in the SON {#sec3.2}
-----------------------------------------------------------------------------------------------------------------------------------------------

We performed quantitative dual fluorescent analysis of Thy-1, α~V~ integrin, ß~3~ integrin, and ß~5~ integrin to identify the cells that express these CAMs within the SON. We observed robust immunoreactivity for Thy-1 in neuronal somata distributed throughout the SON and dual-label immunocytochemistry confirmed the presence of Thy-1-immunoreactivity associated with both oxytocinergic ([Figure 3](#fig3){ref-type="fig"}a-c) and vasopressinergic (not shown) magnocellular neurons. While the Thy-1 immunoreactive profiles were consistently found in the magnocellular neurons of the SON, we only sporadically observed Thy-1 colocalization within GFAP-immunoreactive astrocytes in the SON ([Figure 3](#fig3){ref-type="fig"}d-f). Using the colocalization colormap plugin for ImageJ, we quantified the levels of Thy-1-immunoreactivity and our results demonstrated significantly more Thy-1-immunoreactivity was present in neurons compared to astrocytes (*p=0.001*; [Figure 3](#fig3){ref-type="fig"}g).Figure 3Thy-1-immunoreactivity is consistently colocalized to neurons and sporadically with astrocytes in the SON. Dual fluorescent colocalization of anti-Thy-1 (a) with anti-oxytocin (b) revealed prominent colocalization of Thy-1-immunoreactivity to oxytocinergic neurons (c, arrows). Still present, but less commonly observed was Thy-1-immunoreactive profiles (d) colocalized to GFAP-immunoreactive astrocytes (e) in the SON (f, arrows). Quantitative analysis of Thy-1-immunoreactivity in the SON was performed using the colocalization colormap script, ImageJ plugin. Analysis demonstrated significantly more Thy-1-immunoreactivity was found in the neurons compared to the astrocytes of the SON (g; *p=0.001*). Each shape on the graph indicates an individual data point with the lines representing the mean and SD. OT, oxytocinergic. Scale bars = 30 μm.Figure 3

Dual fluorescent analysis of the integrin subunits demonstrated weak, but consistent cytosolic immunoreactivity for α~V~ integrin in neuronal somata with more robust α~V~ integrin-immunoreactivity in the ventral glial limitans (VGL), which is the primary location for the GFAP-immunoreactive astrocytes in the SON. Quantitative analysis demonstrated consistent levels of α~V~ integrin-immunoreactive profiles in both neurons ([Figure 4](#fig4){ref-type="fig"}a-c) and astrocytes ([Figure 4](#fig4){ref-type="fig"}d-f) in the SON (*p=0.0762*; [Figure 4](#fig4){ref-type="fig"}g). Similarly, we observed robust, cytosolic immunoreactivity for ß~3~ integrin throughout the entire SON and found ß~3~ integrin-immunoreactive profiles co-localized with vasopressinergic magnocellular neurons (data not shown) and oxytocinergic magnocellular neurons ([Figure 5](#fig5){ref-type="fig"}a-c). Even though ß~3~ integrin-immunoreactivity was weak in the VGL of the SON, we did observe consistent colocalization with astrocytes in the SON ([Figure 5](#fig5){ref-type="fig"}d-f) and quantification demonstrated no difference in ß~3~ integrin colocalization between neurons or astrocytes (*p=0.119*; [Figure 5](#fig5){ref-type="fig"}g). We observed a consistent band of ß~5~ integrin-immunoreactivity in the VGL of the SON with robust ß~5~ integrin-immunoreactivity throughout the rest of the SON. Our results demonstrated colocalization of ß~5~ integrin protein in vasopressinergic magnocellular neurons ([Figure 6](#fig6){ref-type="fig"}a-c), oxytocinergic magnocellular neurons (data not shown), and GFAP-immunoreactive astrocytes of the SON ([Figure 6](#fig6){ref-type="fig"}d-f). Quantification demonstrated no difference in the ß~5~ integrin colocalization between neurons or astrocytes (*p=0.4018*; [Figure 6](#fig6){ref-type="fig"}g). Altogether, the results of our dual fluorescent analysis indicate that Thy-1, α~V~ integrin, ß~3~ integrin, and ß~5~ integrin are co-localized to neurons and astrocytes of the SON.Figure 4α~V~ integrin-immunoreactivity is colocalized to neurons and astrocytes in the SON. Dual fluorescent colocalization of anti-α~V~ integrin (a) with anti-oxytocin (b) revealed α~V~ integrin-immunoreactivity in oxytocinergic neurons (c, arrows). Strong α~V~ integrin-immunoreactivity in the VGL of the SON (d) colocalized to GFAP-immunoreactive astrocytes (e) of the SON (f, arrows). Quantitative analysis of α~V~ integrin-immunoreactivity in the SON was performed using the colocalization colormap script, ImageJ plugin. The results demonstrated similar levels of α~V~ integrin-immunoreactivity in both neurons and astrocytes of the SON (g; *p=0.0762*). Each shape on the graph indicates an individual data point with the lines representing the mean and SD. OT, oxytocinergic neurons. Scale bars = 30 μm.Figure 4Figure 5ß~3~ integrin-immunoreactivity is colocalized to neurons and astrocytes in the SON. Prominent ß~3~ integrin-immunoreactive profiles (a) were co-localized to oxytocinergic neurons (b) in the SON (c). Consistent ß~3~ integrin-immunoreactive profiles (d) were also colocalized to GFAP-immunoreactive astrocytes (e) in the VGL of the SON (f). Quantification of ß~3~ integrin-immunoreactivity in the SON was performed using the colocalization colormap script, ImageJ plugin. Analysis demonstrated consistent levels of ß~3~ integrin-immunoreactivity in both neurons and astrocytes of the SON (g; *p=0.119*). Each shape on the graph indicates an individual data point with the lines representing the mean and SD. OT, oxytocinergic neuron. Scale bars = 30 μm.Figure 5Figure 6ß~5~ integrin-immunoreactivity is colocalized to neurons and astrocytes in the SON. Strong ß~5~ integrin-immunoreactivity was colocalized with vasopressinergic neurons (a--c) and GFAP-immunoreactive astrocytes in the SON (d-f; inset in f). Note the arrows in (d) illustrating ß~5~ integrin-immunoreactivity highly present in the VGL. Quantification of ß~5~ integrin-immunoreactivity in the SON was performed using the colocalization colormap script, ImageJ plugin. Analysis demonstrated uniform levels of ß~5~ integrin-immunoreactivity in both neurons and astrocytes of the SON (g; *p=0.4018*). Each shape on the graph indicates an individual data point with the lines representing the mean and SD. VP, vasopressinergic neuron. Scale bars = 100 μm; Scale bar in inset = 30 μm.Figure 6

4. Discussion {#sec4}
=============

Multiple reports establish that the brain is less plastic with age, and thus, the ability to functionally recover following injury is diminished in older animals ([@bib48]; [@bib11], [@bib12]; [@bib35]; [@bib26]). It remains to be determined what facilitates the age-dependent decline in plasticity in the CNS, but several hypotheses exist, many of which are focused on age-dependent changes in anti-sprouting or pro-sprouting molecules. We have demonstrated that the same injury induces collateral sprouting from uninjured axons in 35d rat, but not in the 125d rat ([@bib55]; [@bib54]; [@bib5]). Our and others' research supports our hypothesis that CNTF promotes the axonal sprouting in the SON of 35d rats ([@bib52], [@bib53]; [@bib2], [@bib3]) and our interest in Thy-1 and integrins arises from the evidence that in the rat SON the astrocytes are the only cell capable of directly responding to CNTF due to astrocytic localization of the tripartite CNTF receptor complex ([@bib2]). Moreover, CNTF is inhibited via Thy-1-α~V~ß~5~ integrin interaction and the absence of neuron-astrocyte interaction increases CNTF *in vitro* ([@bib28]; [@bib30]). Thus, understanding the presence of CAMs in the SON may help determine how CNTF can induce astrocytes to communicate with neurons to promote postinjury neuroregenerative responses.

During early development, neuronal expression of Thy-1 is low, but Thy-1 increases in neurons with age ([@bib56]; [@bib9]). Additionally, Thy-1 is not expressed on axons until axonal growth is complete ([@bib40]; [@bib57]), and increased Thy-1 expression with age has been shown to block neuronal repair in astrocyte-rich regions of the mature brain ([@bib49]). Since Thy-1 gradually increases with age in the brain, the increase in Thy-1 protein in the SON that we observed is not surprising. However, it remains to be determined if increased Thy-1 prevents axonal outgrowth or if the cessation of axonal outgrowth increases Thy-1. It should be noted that there are reports that Thy-1 promotes axon outgrowth ([@bib14]; [@bib15]), though, the majority of the literature suggests that Thy-1 functions as an axon outgrowth inhibitor, possibly by clustering Thy-1 and stabilizing the surface-membrane complexes formed by Thy-1 with the underlying cytoskeleton ([@bib23], [@bib24]). Considering the numerous reports indicating the role of Thy-1 in preventing axon growth and our previous reports demonstrating the absence of axonal sprouting following injury in the 125d rat, our data demonstrating increased Thy-1 in the 125d rat SON suggests that Thy-1 may be involved in prohibiting the sprouting response in the 125d rat that normally occurs following injury in the 35d rat SON, when there is significantly less Thy-1 present.

Cellular localization of Thy-1 and integrin subunits in the SON had not been reported, although Thy-1 was previously localized to axons of magnocellular neurons in the NL but not to the resident astrocytes of the NL, pituicytes ([@bib37]). We extended the results of [@bib37], and demonstrated Thy-1-immunoreactivity in the somata of the magnocellular neurons in the SON, but unlike the previous report, we found sporadic GFAP-positive astrocytes co-localized with Thy-1-immunoreactivity in the SON. The astrocytes in the SON and the pituicytes in the NL are quite different functionally and in the genes that they express. It should be noted that there are reports demonstrating Thy-1 localization on astrocytes, although these investigators utilized cultured astrocytes ([@bib42]; [@bib31]; [@bib16]; [@bib25]; [@bib10]). Nonetheless, it was suggested by [@bib10], that astrocytic Thy-1 is most abundant on cells in contact with neurons. In the SON, it is well established that the astrocytic processes provide extensive ensheathment of neurons and dendrites by projecting dorsally from the VGL ([@bib46]), providing possible clarification why we observed Thy-1-positive astrocytes in the SON. We also observed α~V~ integrin-, ß~3~ integrin-, and ß~5~ integrin-immunoreactivity on both neurons and astrocytes in the SON, suggesting that astrocytic Thy-1 may be able to bind to neuronal α~V~ß~3~ or α~V~ß~5~. However, the results of our integrin colocalization studies do not demonstrate the dimerization of the integrin subunits on the neurons or astrocytes in the SON. Future experiments will be performed to determine what, if any, integrins are dimerized in the SON, what the interacting ligands for Thy-1 are in the SON, and the cells directly involved in these interactions.

In summary, the results presented here demonstrate a significant increase in Thy-1 in the SON of a rat at the age when uninjured axons do not elicit a collateral sprouting response following axotomy. It remains to be determined if the increase in Thy-1 prevents the collateral sprouting response; however, given our recent observations that CNTFRα is significantly decreased in the rat SON at the same age that Thy-1 is elevated, our current hypothesis is that there is not one specific factor that prevents the collateral sprouting response. Rather, we hypothesize that a combination of age-related changes in intrinsic and extrinsic factors occur in the SON that collectively decreases the ability to functionally recover following injury.
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